A 33-year-old woman with poorly controlled diabetes mellitus presents with epigastric discomfort, early satiety, and nausea. Vital signs: BP 118/76 mmHg, HR 88/min, RR 16/min, temp 37°C, SpO2 98% on room air. She denies hematemesis or melena. Upper endoscopy shows delayed gastric emptying with no ulceration. Fasting glucose is 186 mg/dL. She is started on a medication that improves gastric motility and blocks D2 receptors in the chemoreceptor trigger zone. Which medication most likely produces this dual mechanism?
- A)Aprepitant
- B)MetoclopramideGABARITO
- C)Ondansetron
- D)Omeprazole
- E)Loperamide
Explicação
Metoclopramide is a D2 antagonist with both antiemetic and prokinetic effects. Extrapyramidal symptoms and hyperprolactinemia are important adverse effects. Ver explicação completa e trilha adaptativa →